AIM
KURA icon

Aigen Investment Management’s Kura Oncology KURA Stock Holding History

Aigen Investment Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,403
Closed -$64K – 1073
2020
Q1 		$64K Sell
6,403
-6,231
-49% -$71.3K 0.01% 939
2019
Q4 		$174K Buy
+12,634
New +$187K 0.03% 587

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Aigen Investment Management's KURA Position: Q2 2020 in Review

Aigen Investment Management sold out of Kura Oncology (KURA) in Q2 2020, closing a stake of 6,403 shares — an estimated $64K sold.

Aigen Investment Management first reported a position in KURA in Q4 2019 and held it in 2 quarters. The position peaked at $174K in Q4 2019. 134 funds tracked by Wall St. Rank hold KURA as of Q2 2020.

  • Aigen Investment Management reported no remaining Kura Oncology position as of Q2 2020 after selling out during the quarter.
  • Aigen Investment Management sold 6,403 Kura Oncology shares in Q2 2020, an estimated $64K.
  • Aigen Investment Management first reported a position in Kura Oncology in Q4 2019 and held it in 2 quarters.
  • Aigen Investment Management's Kura Oncology position peaked at $174K in Q4 2019.
  • 134 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2020.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.